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Different from other epithelia, the intestinal epithelium has the complex task of providing
a barrier impeding the entry of toxins, food antigens, and microbes, while at the
same time allowing for the transfer of nutrients, electrolytes, water, and microbial
metabolites. These molecules/organisms are transported either transcellularly, crossing
the apical and basolateral membranes of enterocytes, or paracellularly, passing through
the space between enterocytes. Accordingly, the intestinal epithelium can affect energy
metabolism, fluid balance, as well as immune response and tolerance. To help
accomplish these complex tasks, the intestinal epithelium has evolved many sensing
receptor mechanisms. Yet, their roles and functions are only now beginning to be
elucidated. This article explores one such sensing receptor mechanism, carried out by
the extracellular calcium-sensing receptor (CaSR). In addition to its established function
as a nutrient sensor, coordinating food digestion, nutrient absorption, and regulating
energy metabolism, we present evidence for the emerging role of CaSR in the control
of intestinal fluid homeostasis and immune balance. An additional role in the modulation
of the enteric nerve activity and motility is also discussed. Clearly, CaSR has profound
effects on many aspects of intestinal function. Nevertheless, more work is needed to
fully understand all functions of CaSR in the intestine, including detailed mechanisms
of action and specific pathways involved. Considering the essential roles CaSR plays
in gastrointestinal physiology and immunology, research may lead to a translational
opportunity for the development of novel therapies that are based on CaSR’s unique
property of using simple nutrients such as calcium, polyamines, and certain amino
acids/oligopeptides as activators. It is possible that, through targeting of intestinal CaSR
with a combination of specific nutrients, oral solutions that are both inexpensive and
practical may be developed to help in conditioning the gut microenvironment and in
maintaining digestive health.
Keywords: intestinal barrier function, enteric nervous system, gut immunity, secretory diarrhea, motility, irritable
bowel syndrome, inflammatory bowel disease, calcium-sensing receptor
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INTRODUCTION
The intestinal epithelium is faced with the complex task of
providing a barrier impeding the entry of noxious substances
and microbes, while concurrently allowing for nutrient and
water absorption and secretion. The primary function of the
gastrointestinal (GI) tract is to digest food and absorb nutrients.
To aid in digestion, the GI tract secretes a large amount of fluid
to mix the food components and to lubricate the surface of the
lumen. It is estimated that in a 24-h period, an average of 7.0 L of
digestive juices are secreted upon food ingestion. These include
1.5 L from the salivary glands, 2.5 L from the stomach, 0.5 L
from the biliary system, 1.5 L from the pancreas, and 1.0 L from
the intestine (Boron and Boupaep, 2008). Upon completion of
digestion and extraction of nutrients, these secretions must be
reabsorbed along with released nutrients while also ensuring that
further post-digestive secretions do not occur. These processes
are highly regulated and coordinated; failure to do so may result
in diseases such as mal-digestion, mal-absorption, constipation,
or diarrhea.
The mammalian gut is considered the largest immune organ
in the body. It is estimated that 65–80% of the body’s immune
cells (e.g., macrophages, dendritic cells, T cells, and B cells) and
over 90% of immunoglobulin-producing cells are found in the
gut, residing in ∼100,000 isolated lymphoid follicles in the sub-
epithelium lamina propria layer of the mucosa (Brandtzaeg et al.,
1989). Adjacent to the epithelium is the lumen of the intestine,
where, in addition to food and nutrients, hundreds of trillions of
microorganisms reside. These include microbes that benefit the
host, as well as those that cause disease. Additionally, during food
ingestion, foreign antigens are being continuously introduced
into the GI tract, and these molecules may also pose threats to the
body. Accordingly, the GI tract must maintain an intact epithelial
barrier and reliable immunity. The GI tract has the innate ability
to control the flow of nutrients across the epithelium where the
nutrients are absorbed, while also restricting microbes and food
antigens to the lumen. In this manner, the immune cells of the
gut are prevented from over-activation, and consequently, no
inflammation, allergic reaction, or hypersensitivity results.
Notably, the mammalian epithelium lining the GI tract
is a specially adapted tissue equipped with sensing receptor
mechanisms. These sensing receptors are constantly detecting
and responding to changes in the composition of local nutrient
milieus and microbial environment. This constant monitoring
by receptors ensures that the gut absorbs and secretes according
to the state of digestion and nutrient availability, and that
it alters intestinal permeability and immunity in accordance
with the status of flora. One such sensing mechanism is the
extracellular calcium-sensing receptor (CaSR), a multifaceted
heptahelical guanine nucleotide-binding protein (G protein)-
coupled receptor (GPCR; Brown et al., 1993).
In this article, after briefly exploring the function of CaSR
as a nutrient sensor along the mammalian GI tract, we
discuss the emerging roles this receptor may play in regulating
colonic secretion, absorption, motility, epithelial integrity, and
immunity. The role of CaSR in the regulation of colonic
epithelial proliferation/tumorigenesis, differentiation, and stem
cell growth and renewal has been reviewed elsewhere (see
referencesWhitfield, 2009; Ghevariya andAnand, 2011;Macleod,
2013a; Singh et al., 2013; Tennakoon et al., 2016; also in
the article by Kallay and colleagues and the discussion by
MacLeod, et al in this issue) and is therefore not discussed here,
even though it is very important for maintenance of intestinal
barrier integrity/immunity. A general approach that was used
to verify the role of CaSR in the studies presented here is
either pharmacological, using the specific CaSR inhibitors (e.g.,
NPS 2143, calhex 231) or activators (e.g., R568, cinacalcet), or
genetic, by comparing the behavior difference between mice
that lack CaSR vs. their wild type controls. Both global CaSR
exon 5 null mice [e.g., Casr−/−PTH−/− (Kos et al., 2003)
and Casr−/−Gcm2−/− (Tu et al., 2003)] and intestine-specific
CaSR exon 7 null mice [e.g., villinCre/Casrflox/flox Rey O et al.,
2012] are generated and successfully used. Double global CaSR
knockout mice are used because deletion of the CaSR gene
alone results in early death from the toxic effects of unregulated
release of parathyroid hormone (PTH) from parathyroid chief
cells as well as from the pathological effects of the consequent
hypercalcemia (Ho et al., 1995). As a result, double knockouts
with simultaneous ablation of additional PTH gene (as in
Casr−/−PTH−/−) or gene that regulates PTH (e.g., Gcm2 as in
Casr−/−Gcm2−/−) are generated to “rescue” the lethal CaSR-
deficient phenotype.
CaSR AND NUTRIENT-SENSING
CaSR is a well-conserved ancient GPCR, originally cloned from
bovine parathyroid glands (Brown et al., 1993) and then found in
rat kidney (Riccardi et al., 1995). There, it acts as an extracellular
calcium ion (Ca2+o ) sensor and provides a key negative feedback
mechanism for Ca2+o to regulate parathyroid hormone secretion
and urinary Ca2+o excretion, thereby maintaining systemic Ca
2+
o
homeostasis (Brown and MacLeod, 2001; Hofer and Brown,
2003). It was subsequently found in other tissues of diverse
species that are not typically associated with Ca2+o homeostasis,
thereby suggesting that this receptor may subserve other roles
and functions beyond systemic Ca2+o homeostasis.
Importantly, CaSR is a member of the class C GPCR that
uses nutrients as agonists. This receptor, therefore, not only
senses ions, but may also recognize and respond to nutrients
in the milieus. Like other members in this family of GPCRs,
such as metabolic glutamate receptors, gamma amino butyrate
B receptors, sweet, and umami taste receptors, and pheromone
receptors, CaSR is structurally equipped with an unusually
large extracellular domain (∼50% of the receptor mass) called
the Venus fly trap module. Studies suggested that this Venus
fly trap domain is located outside of the cell and senses
nutrients, specifically protein breakdown products [e.g., amino
acids (Conigrave et al., 2000; Mun et al., 2004), peptides
(Conigrave and Brown, 2006; Wang et al., 2006; Broadhead et al.,
2011), and polyamines (Quinn et al., 1997)] as well as other
environmental cues [e.g., ionic strength and pH (Quinn et al.,
2004)]. Considering that these nutrients/conditions are routinely
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encountered by cells/tissues in the GI tract, this nutrient sensor
may play crucial roles in GI physiology.
Indeed, CaSR has been widely detected in tissues and cell
types in the GI tract and its accessory organs that are implicated
in nutrient sensing and/or nutrient handling. These include
the taste cells in the taste buds of the tongue, the gastrin-
secreting G cells, and the cholecystokinin (CCK)-secreting K cells
in the stomach and duodenum, the nutrient-absorbing villous
cells in the small intestine, the short chain fatty acid (SCFA)-
absorbing surface cells in the large intestine, and the enteric
nervous system (ENS; see summary in Table 1). In these cells
and tissues, CaSR may act as a nutrient sensor, monitoring, and
coordinating digestion, secretion and absorption. For example, in
the mouth, which is the beginning of the sensory portion of the
gut, CaSR may allow the taste cells to chemo-sense bitter taste
(calcium), and kokumi taste (γ-glutamyl peptides; Ohsu et al.,
2010; Maruyama et al., 2012), thus facilitating food ingestion. In
the digestive gut (i.e., the stomach and duodenum), this nutrient
sensor may enable the gastrin cells and the CCK cells to detect
the arrival of food, stimulate digestive secretions, and initiate
postprandial food digestion. In support of this notion, the gastric
G cells in wild type mice or cells were found to release gastrin
upon activation by luminal calcium, phenylalanine, peptone,
spermine, or the calcimimetic Cinacalcet (Ray et al., 1997),
but not those G cells in CaSR-pharmacologically inhibited
or genetically ablated (Casr−/−PTH−/−) mice (Feng et al.,
2010). Similar observations were made in the intestinal I cells,
which responded to luminal nutrients, calcium, phenylalanine,
tryptophan and peptides, and secreted CCK only in wild type
mice or cells, but not in CaSR-null (Casr−/−PTH−/−) mice
(Liou et al., 2011) or CaSR activity-inhibited cells isolated from
wild type mice (Wang et al., 2011). These findings point to the
significance of CaSR in nutrient sensing in the gut.
In the absorptive gut (i.e., the jejunum and ileum) where
dietary nutrients are fully released and extracted from ingested
food, CaSR may function to inform the villus cells of the
availability of nutrients, to activate absorption, and to provide
a mechanism to signal to the ENS, coined “the brain of the
gut,” to coordinate food delivery and gut motility in order
to maximize nutrient absorption. In this latter part of the
gut, CaSR has also been found to be present in a number
of enteroendocrine cells, including the glucagon-like peptide-1
(GLP-1)-secreting L cells (Mace et al., 2012; Pais et al., 2016),
the glucose-dependent insulinotropic peptide (GIP)-secreting K
cells (Mace et al., 2012), and the insulin-secretion β cells of the
pancreatic Islets of Langerhans (Leech and Habener, 2003). Since
the main function of GLP-1 and GIP is to enhance glucose-
induced insulin secretion from β cells, it is possible that CaSR
may play a role in nutrient (glucose/SCFA) utilization and energy
homeostasis, through regulating the postprandial secretion of
GLP-1, GIP, and insulin. Indeed, oral or duodenal administration
of CaSR peptide agonists to experimental animals reduced rapid
elevation of plasma glucose in response to oral glucose challenge
(Muramatsu et al., 2014). Further, evidence supporting the role
of CaSR as a nutrient sensor and food metabolism regulator
comes from the discovery that CaSR is found in tissues that
regulate appetite and satiety. In addition to the duodenal I
cells that secrete satiety-inducing CCK, there is evidence that
gastric ghrelin cells, which secrete ghrelin (a hunger hormone),
express CaSR, too (Engelstoft et al., 2013; Vancleef et al., 2015).
Thus, CaSR may participate in the regulation of food intake.
Taken together, it is tempting to speculate that modulations
of intestinal CaSR expression and function by calcimimetics
or nutritional receptor agonists may alter the behavior of food
intake and energy metabolism thus providing a novel pathway
for prevention and treatment of both obesity and type 2 diabetes
mellitus.
CaSR AND INTESTINAL ABSORPTION
AND SECRETION
In addition to digesting food, the GI tract moves a large
amount of fluid and electrolytes. Accordingly, CaSR may also
regulate intestinal fluid homeostasis and electrolyte balance.
Normally, fluid moves across and along the intestine. While the
fluid movement across the intestine [absorption (Figure 1A) or
secretion (Figure 1B)] is driven by active epithelium transport
of electrolytes (mainly Na+, Cl−, and HCO−3 ) and solutes
(mainly glucose in the small intestine and SCFAs in the large
intestine), the fluid moving along the intestine (anterograde
or retrograde) is governed by gut motility (see Figure 1D).
The ENS, the brain of the gut, controls both processes, with
absorption/secretion regulated by the submucosal Meissner’s
plexus, and the motility under the control of the myenteric
Auerbach’s plexus (see Figure 1D). CaSR has been identified
on the apical and basolateral membranes of fluid-absorbing
villous/surface cells and fluid-secreting crypt cells of rat and
human intestines (Chattopadhyay et al., 1998; Cheng et al., 2002),
as well as on the Meissner’s and Auerbach’s plexuses of the ENS
(Chattopadhyay et al., 1998; Cheng, 2012). Receptors in both
membrane domains of these polarized epithelia, as well as the
ENS, are functionally active (Chattopadhyay et al., 1998; Cheng
et al., 2002; Cheng, 2012; Tang et al., 2015) and can be activated
by Ca2+o (Cheng et al., 2002, 2004; Geibel et al., 2006), polyamines
(Cheng et al., 2004), and the specific pharmacologic CaSR agonist
R568 (a calcium mimetic drug; Geibel et al., 2006; Tang et al.,
2015), suggesting its likely role in regulation of intestinal fluid
metabolism.
Activation of CaSR Inhibits Anion Secretion
The first evidence that suggests the modulation of intestinal
fluid metabolism by CaSR was made in perfused crypts isolated
from rat colons (Cheng et al., 2002). In this study, the effect of
increasing either luminal or basolateral Ca2+o on the direction
and rate of net fluid movement (netJv) was determined in isolated
rat distal colonic crypts in both basal and forskolin (cAMP)-
stimulated states. Colonic crypt is a typical fluid-transporting
epithelium that is able to move fluid in two directions.
Depending on the presence or absence of secretagogues and/or
anti secretagogues and their relative forces in the milieus, the
fluid can be transported either from the luminal side to the
vascular side, resulting in net fluid absorption or positive netJv,
or from the blood side to the luminal side, resulting in net
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TABLE 1 | CaSR and modulations of digestive functions.
Cell types that express Activating nutrient(s) Role and function Type of
evidence
References
CELLS THAT REGULATE INGESTION AND DIGESTION
Tongue
Taste buds Ca2+o , γ-glutamyl peptide ↑bitter and kokumi taste perception Pharmacological Ohsu et al., 2010; Maruyama et al.,
2012
Esophagus
Epithelial cells (basal cells) Inflammation-modulating (?) Biochemical Justinich et al., 2008;
Abdulnour-Nakhoul et al., 2015
Stomach
G cells (ap & bl) Ca2+o , Phe, spermine, Peptide,
cinacalcet
↑gastrin ↑gastric H+ production Pharmacogenetic Ray et al., 1997; Buchan et al., 2001
D cells Biochemical Haid et al., 2012; Adriaenssens et al.,
2015
Ghrelin cells (ap & bl) Phe, Ala, peptide ↑and ↓ghrelin secretion Pharmacological Engelstoft et al., 2013; Vancleef et al.,
2015
Parietal cells (bl) Ca2+o , Mg
2+, amino acid ↑gastric H+ secretion Biochemical Cheng et al., 1999; Caroppo et al.,
2001; Geibel et al., 2001; Busque
et al., 2005; Dufner et al., 2005
Mucous cells (ap & bl) Ca2+o ↑mucous secretion Biochemical Rutten et al., 1999; Gilster et al., 2004
Duodenum
I cells (ap & bl) Ca2+o , Phe, Trp, peptide ↑CCK ↑pancreatic juice & bile Pharmacogenetic Sheinin et al., 2000; Hira et al., 2008;
Nakajima et al., 2010, 2012; Liou
et al., 2011; Wang et al., 2011
Pancreas
Acinar cells ↑ secretion of pancreatic juice (?) Biochemical Bruce et al., 1999
Ductal cells (ap) Ca2+o ↑pancreatic fluid flow & solubility Biochemical Bruce et al., 1999
α & β cells of Islet Ca2+o , L-His ↑insulin ↑nutrient utilization Biochemical Bruce et al., 1999; Squires et al.,
2000; Komoto et al., 2003; Leech
and Habener, 2003
Liver
Hepatocytes Ca2+o , spermine ↑bile flow Biochemical Canaff et al., 2001
Cholangiocytes (?)
CELLS THAT REGULATE ABSORPTION AND SECRETION
Small intestine
Villus cells (ap & bl) ↑absorption Biochemical Chattopadhyay et al., 1998
K cells Ca2+o , amino acid ↑GIP ↑insulin/nutrient utilization Pharmacological Mace et al., 2012
L cells Ca2+o , amino acid, peptide ↑GLP-1 ↑insulin/nutrient utilization Pharmacological Leech and Habener, 2003; Mace
et al., 2012; Diakogiannaki et al.,
2013; Pais et al., 2016
Colon
Surface & crypt cells (ap &
bl)
Ca2+o , polyamine, R568 ↑absorption; ↓secretion Pharmacogenetic Chattopadhyay et al., 1998; Cheng
et al., 2002; Cheng, 2012
↑barrier function; ↑gut immunity Pharmacogenetic Jouret et al., 2013; Macleod, 2013b;
Cheng et al., 2014
↓proliferation; ↑differentiation Pharmacogenetic Chakrabarty et al., 2003; Rey O et al.,
2012; Aggarwal et al., 2015
↓colon cancer Pharmacogenetic Kallay et al., 2000; Sheinin et al.,
2000; Singh and Chakrabarty, 2013;
Aggarwal et al., 2015; Singh et al.,
2015
CELLS THAT REGULATE OTHER FUNCTIONS
Myofibroblasts Ca2+o ↑wnt5a and BMP-2 secretion Biochemical Peiris et al., 2007; Pacheco and
Macleod, 2008
ENS peptide, R568 ↓secretion; ↓motility Pharmacological Chattopadhyay et al., 1998; Cheng,
2012; Muramatsu et al., 2014
Immune cells Ca2+o ↓inflammation Biochemical Kelly et al., 2011
Ala, alanine; ap, apical membrane; bl, basolateral membrane; Ca2+o , extracellular calcium; CCK, cholecystokinin; ENS, enteric nervous system; GIP, glucose-dependent insulinotropic
peptide; GLP-1, glucagon-like peptide-1; Phe, phenylalanine; PYY, peptide tyrosine tyrosine; Trp, tryptophan.
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FIGURE 1 | Schematic diagram illustrating pathways and mechanisms through which CaSR-activating calcimimetics and agonists modulate GI
physiology and immunophysiology. Known CaSR effects include: (A) increased absorption, (B) decreased secretion, (C) enhanced intestinal barrier and reduced
inflammation, and (D) reduced enteric nerve activity and motility (see text for explanations). CaSR, calcium-sensing receptor; CFTR, cystic fibrosis transmembrane
conductance regulator; PDE, phosphodiesterase; SCFA, short-chain fatty acid; VIP, vasoactive intestinal peptide; +, stimulation; –, inhibition.
fluid secretion or negative netJv. The study showed that, in
the absence of the secretagogue, the colonic crypt exhibited
a positive netJv, indicating net fluid absorption; exposure of
crypts to the cAMP-elevating secretagogue forskolin induced
net fluid secretion; increasing Ca2+o in either the luminal or
vascular perfusate abolished the stimulatory effect of forskolin
on net fluid secretion. In the presence of increased Ca2+o , net
fluid secretion induced by forskolin was completely reversed,
resulting in net fluid absorption (Cheng et al., 2002). Although
the concentrations of Ca2+o used in this study (2 and 5 mM)
were slightly higher than the Ca2+o concentrations in the blood
and may be less physiological, the finding suggested a potential
role for Ca2+o acting via CaSR in regulating intestinal fluid
movement.
A subsequent study used this CaSR-modulated response to
further assess the interactions of spermine and Ca2+o (Cheng
et al., 2004). In this study, the effect of increasing luminal
or basolateral polyamine on forskolin-stimulated netJv was
examined in the presence of a fixed dose of Ca2+o . Three doses of
Ca2+o were tested: the threshold (0.1 mM), the near physiological
(0.5 mM), and the physiological (1.0 mM). Similar to increasing
Ca2+o , addition of the polyamine spermine to either the luminal
or basolateral perfusate dose dependently reversed net fluid
secretion to absorption; the extent to which spermine reduced
the net fluid transport depended on the concentration of Ca2+o .
Thus, at a threshold dose of Ca2+o , millimolar or sub-millimolar
concentrations of spermine were required to reverse the secretory
netJv; on the other hand, when a physiological Ca
2+
o was present,
a much lower concentration (low micromolar) of spermine was
needed to reverse the direction of forskolin-stimulated netJv
(Cheng et al., 2004). The latter is the polyamine concentration
most often seen in breast milk (Pollack et al., 1992; Romain et al.,
1992; Buts et al., 1995) but not in infant formulas [in which
the polyamine concentration is at least 1 order of magnitude
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lower than in breast milk and 2–3 orders of magnitude lower
than the polyamine concentration in the lumen of the intestine
shortly after ingestion of a typical adult human meal (see reviews
Bardócz et al., 1995; Ralph et al., 1999; Milovic, 2001)]. Thus, it
is conceivable that supplementation of oral rehydration solution
or infant formulas with polyamines may be beneficial in treating
children with diarrhea.
A definitive study that established the role for the colonic
CaSR in regulating intestinal fluid secretion was the comparison
of secretagogue-stimulated netJv responses to Ca
2+
o and R568
in colonic crypts of CaSR null mice (Casr−/−Gcm2−/−) with
the wild type controls (Casr+/+Gcm2+/+) (Geibel et al., 2006).
It showed that CaSR, activated from either the mucosal or
serosal side by Ca2+o or R568, reduced secretagogue-stimulated
net fluid secretion in colonic crypts of wild type mice, but not
in colonic crypts from CaSR null mice. In CaSR null mice,
colons responded to cholera toxin or guanylin with stimulated
fluid secretion but, unlike the wild type controls, failed to
generate the inhibitory actions of Ca2+o or R-568 (Geibel et al.,
2006). Speculating that CaSR may inhibit fluid secretion through
inhibiting cyclic nucleotide accumulation or metabolism, levels
of colonocyte cAMP, and cGMP were measured. As expected,
stimulation of adenylyl cyclase with forskolin or cholera toxin
increased cytosolic cAMP, and stimulation of guanylyl cyclase
with guanylin or the Escherichia coli heat-stable enterotoxin STa
increased cytosolic cGMP; increased Ca2+o or R568 abolished
these effects (Geibel et al., 2006). Similar inhibitory effects were
seen for spermine in isolated human colonic mucosa (Rogers
et al., 2015). Interestingly, the CaSR-mediated inhibitory effects
on cyclic nucleotides as well as on increased fluid secretion
were prevented by the phosphodiesterase (PDE) inhibitor IBMX
(Geibel et al., 2006). Similar preventative effects on CaSR were
also produced by inhibition of phospholipase C (PLC) by U73122
(Geibel et al., 2006) or by depletion of inositol trisphosphate
(IP3)-sensitive intracellular Ca
2+ stores by thapsigargin (Cheng
et al., 2002). These in vitro studies strongly support the notion
that activation of CaSR in the colon inhibits fluid secretion
through receptor-mediated destruction of cyclic nucleotides by
PDE using a signaling pathway that activates PLC-IP3- Ca
2+
i (see
Figure 1B).
Cl− Secretion
Fluid secretion is driven primarily by transepithelial anion (e.g.,
Cl−) secretion (Barrett and Keely, 2000; Kere and Höglund,
2000; Kunzelmann and Mall, 2002). The next question that was
examined was whether CaSR activation inhibits transepithelial
Cl− secretion. The secretion of Cl− into the lumen of the
intestine requires two separate, but interconnected movements:
Cl− entry from the blood into the cell and Cl− exit from the
cell into the lumen (see Figure 1B). The egress of the anion is
conducted through apical membrane anion channels primarily
the cAMP-dependent, 5-nitro-2-(3-phenylpropylamino)
benzoic acid (NPPB)/glibenclamide-sensitive cystic fibrosis
transmembrane conductance regulator chloride channels
(CFTR), whereas the entry of Cl− is critically dependent on
the activity of the basolateral membrane bumetanide-sensitive
Na+-K+-2Cl− cotransporter (NKCC1; Kunzelmann and Mall,
2002). Mice deficient in CFTR lack a secretory response to
cholera toxin (Gabriel et al., 1994); similarly, mice lacking
NKCC1 exhibit blunted secretion to cAMP or STa (cGMP)
challenge (Flagella et al., 1999). By measuring short circuit
current (Isc) responses to pharmacological inhibitors of anion
channels in the apical membrane of colonic mucosa mounted in
Ussing chambers, it was shown that CaSR activation inhibited
the cAMP-dependent, NPPB/glibenclamide-sensitive, apical
anion channel activity (Tang et al., 2015). Likewise, by measuring
Cl−-sensitive MQAE fluorescence responses in perfused colonic
crypts, it was also demonstrated that secretagogue-induced,
bumetanide-sensitive, basolateral membrane Cl− entry into
colonocytes was inhibited by either R568 or by increasing [Ca2+o ]
of the basolateral bath fluid, consistent with CaSR inhibition of
NKCC1 (Geibel et al., 2006). Therefore, in colons CaSR inhibits
both Cl− entry and exit. Currently, it remains unknown whether
CaSR directly inhibits these ion transporters or indirectly via the
reversal of changes in cyclic nucleotide by the activation of the
receptor.
HCO−3 Secretion
In addition to Cl− secretion, HCO−3 secretion is increased upon
secretagogue stimulation, and this stimulated HCO−3 secretion
contributes to alkaline deficit and metabolic acidosis, as well as
to systemic volume depletion and dehydration seen in cholera
and other diarrhea conditions (Fordtran, 1967; Powell et al.,
1971). Regulated HCO−3 secretion is also essential for mucosal
defense against luminal acid (via neutralization) in the upper
GI tract and bacteria (via stimulation of mucus secretion and
maintenance of intestinal barrier function) in the lower GI
tract; defects in HCO−3 secretion have been shown to be a risk
factor for peptic ulcer diseases (Isenberg et al., 1987; Flemstrom
and Isenberg, 2001; Allen and Flemström, 2005) and intestinal
inflammation (Garcia et al., 2009; Xiao et al., 2012, 2013). To
assess if CaSR activation inhibits secretagogue-induced HCO−3
secretion, colonic mucosa HCO−3 secretory response to R568
was also studied recently (Tang et al., 2015). In this study, the
cAMP-elevating secretagogue forskolin was employed to induce
HCO−3 secretion, and HCO
−
3 secretion was monitored both
electrophysiologically by recording HCO−3 ion-dependent short-
circuit current (Isc) and chemically through measuring the rate of
HCO−3 secretion (JHCO3) using a so-called “pH stat” technique.
The latter measures the amount of exogenous acid (HCl or
H2SO4) delivered per hour per cm
2 surface area to neutralize the
secreted alkaline (HCO−3 ) in order to maintain a constant lumen
fluid pH. It was found that forskolin stimulated both Isc and
JHCO3 in colonic mucosa of rats, wild type mice, and mice lacking
the intestinal epithelium CaSR (villinCre/Casrflox/flox; Tang et al.,
2015), consistent with active control of HCO−3 secretion in the
intestine by cyclic nucleotide. However, subsequent activation
of CaSR, either apically or basolaterally by R568, significantly
reduced forskolin-induced HCO−3 secretion in colonic mucosa of
rats and wild type mice, but not villinCre/Casrflox/flox (Tang et al.,
2015), suggesting the involvement of CaSR in the inhibition of
HCO−3 secretion. These studies established that CaSR regulates
intestinal HCO−3 secretion.
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Activation of CaSR Enhances Salt and
Solute Absorption
CaSR is also expressed in absorbing villus/surface cells (Table 1),
suggesting critical roles in regulating intestinal absorption (see
Figure 1A). To address this, colonic crypts or mucosa from
rat and mice were isolated, and effects of CaSR agonists on
absorptionwere examined (Geibel et al., 2006). Bidirectional fluid
movements (absorption and secretion) take place in the same
enterocytes. To minimize interference from secretion, in these
studies tissues were first treated with basolateral bumetanide
to block secretion before absorption was investigated. Without
secretagogues, perfused crypts exhibited a positive net Jv (
netJv),
suggesting that under baseline conditions, colonic crypts are in
a net fluid absorption mode. Addition of bumetanide to the
basolateral bath fluid of perfused crypts slightly increased the
absorptive netJv, consistent with inhibition of a small component
of fluid secretion that remains under basal non-stimulated
condition. This low basal fluid secretion is likely attributable
to the low cyclic nucleotide level that remains even in the
absence of secretagogues. Thus, in the presence of bumetanide,
netJv measurements represent the absorptive component of fluid
transport. This absorptive fluid movement was substantially
reduced by exposure to cAMP or forskolin. Activation of CaSR by
either increasing Ca2+o and/or addition of R568 to the basolateral
bath significantly reduced the cAMP-mediated reduction in
absorptive netJv, demonstrating that activation of CaSR not only
suppresses the stimulated fluid secretion but also reverses the
reduced fluid absorption.
Na+ Absorption
Solute absorption in the colon (and the small intestine)
is driven primarily by parallel Na+/H+ (sodium-hydrogen
exchanger, NHE) and Cl−/HCO−3 exchange located at the
apical plasma membranes (see Figure 1A). It is known that
this Na+-dependent fluid absorption in the colon, as well
as in the ileum, is reduced by cholera toxin and other
cyclic nucleotide-elevating enterotoxins via inhibiting NHE
activity and Cl−/HCO−3 exchange (Thiagarajah et al., 2015).
It is also acknowledged that this event contributes to the
severity of fluid and electrolyte losses in secretory diarrheas
(Kunzelmann and Mall, 2002; Field, 2003; Thiagarajah et al.,
2015). Similar to the events in secretory diarrheas, during
normal digestion, vasoactive intestinal peptide (VIP) and other
cyclic nucleotide-stimulating paracrines/autocrines/neurocrines
are generated from enteroendocrine cells and/or the subepithelial
ENS. These secretagogues stimulate intestinal secretion in
distinct ion transport processes that not only increase the
secretory component but also reduce the absorptive component
of transepithelial fluid movement, leading to net digestive
secretion (Barrett and Keely, 2000; Kunzelmann and Mall, 2002).
This secretion helps to mix up food components and to lubricate
the lumen surface of the intestine. To evaluate whether CaSR also
modulates the NHE-mediated Na+ absorptive process, isolated
colonocytes were preloaded with BCECF (a fluorescent probe
for H+ or pH), and effects of CaSR agonists on Na+-dependent
proton extrusion from the apical membrane of colonocytes (a
standard measure of NHE-mediated Na+ absorptive activity)
were studied (Geibel et al., 2006). Raising the basolateral bath
Ca2+o to activate CaSR significantly increased the Na
+-dependent
acid extrusion rate; the addition of R568 resulted in further
elevation of this rate, demonstrating that CaSR stimulates Na+
absorption mediated by NHE.
Cl− Absorption
Does CaSR stimulate Cl− absorption mediated by parallel
Cl−/HCO−3 exchange so as to match the receptor stimulation
of Na+ absorption by the receptor (see Figure 1A)? To answer
this question, in another study, transepithelial Cl− absorption
was measured (Tang et al., 2015). Colonic mucosa were isolated,
mounted into Ussing chambers and perfused, and lumen Cl−-
dependent HCO−3 secretion (a measure of Cl
−/HCO−3 exchange-
mediated Cl− absorptive activity) was recorded and compared in
the presence and absence of R568 stimulation using the Ussing
chamber-pH stat technique (Tang et al., 2015). Similar to the
R568 effects onNa+/H+ exchange, lumenCl−-dependent HCO−3
secretion was found to be significantly stimulated by R568 in the
colons of both rats and wild type mice, but not in CaSR−/− mice
(Tang et al., 2015).
SCFA Absorption
Short-chain fatty acids (SCFAs) are the major anions in stool.
SCFAs are produced in the colon by bacterial fermentation
of unabsorbed carbohydrates. SCFA absorption stimulates
Na+, Cl−, and water absorption and represents a major
mechanism in the colon to conserve fluid and electrolytes (see
Figure 1A). SCFA absorption occurs via a process involving
apical membrane Na+/H+, Cl−/HCO−3 , and SCFA/HCO
−
3
exchanges (Ruppin et al., 1980; Binder, 2010), and Na+/H+
and Cl−/HCO−3 exchanges are stimulated by activation of
CaSR. This combined knowledge led to a hypothesis that
CaSR activation also stimulates SCFA/HCO−3 exchange and
enhances SCFA absorption. To examine this, in a separate
experiment using the same aforementioned Ussing chamber—
pH stat technique, SCFA absorption mediated by SCFA/HCO−3
exchange was measured as lumen isobutyrate-dependent HCO−3
secretion (Tang et al., 2015). Comparable to the R568 effects
on Na+/H+ and Cl−/HCO−3 exchanges, isobutyrate-dependent
HCO−3 secretion was also found to be significantly stimulated by
R568 in the colons of rats and wild type mice, but once again not
CaSR−/− mice (Tang et al., 2015).
Jointly, these studies have established that CaSR is a regulator
of NaCl and SCFA absorption in the colon. These findings are
not surprising considering that CaSR has been shown to be
used by chloride cells of gills, as well as by ion transporting
cells of the kidney and the gut of marine and freshwater fish
alike in order to pump Cl− and other ions to direct water
flow (Nearing et al., 2002); however, these new data provide
compelling support for the notion that CaSR is an important
regulator of intestinal fluid movement. In order to generate the
large quantities of fluid needed for the digestion of ingested food,
the gut has evolved a complex series of neuronal, hormonal,
and/or paracrine/autocrine feedback regulation mechanisms that
allow for the continued production of fluid during the phases of
ingestion and digestion. Moreover, when digestion is complete,
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the gut signals for the induced secretion to stop and for
subsequent absorption to occur. The studies presented suggest
that the nutrients released from food as a result of digestion
may act as signals that activate CaSR in the gut epithelium, and
probably also CaSR in the ENS (see below), thereby initiating and
coordinating transition of these processes.
Besides the aforementioned transporters, apical Na+ and K+
channels, as well as basolateral K+ channels and Na+,K+-ATPase
(Figure 1), also play critical roles in epithelial absorption and
secretion. For example, in Cl− secreting epithelia, the basolateral
K+ channels facilitate basolateral Cl− entry (via cycling back
the K+ for NKCC1), as well as apical Cl− exit (by maintaining
a favorable transepithelial electrical gradient), while Na+,K+-
ATPase pumps the Na+ entered by NKCC1 out of the cell.
Whether CaSR also affects the activity and function of these
transporters remains to be determined.
Also needed to be studied are CaSR effects in vivo. Most
of the studies so far are based on observations from perfused
crypts or use of Ussing chambers. Studying these effects in
isolation can be artificial. Future studies should be directed at
the organismal and systemic levels in order to better define the
net effect of the absence of the gene. In this respect, studies that
characterize the phenotype of CaSR−/− mice (Rey O et al., 2012;
Macleod, 2013b; Cheng et al., 2014) or associate SNPs in CaSR for
diarrheal conditions (Ho et al., 2010; Romero et al., 2015) would
be useful. Nonetheless, preliminary data from animals (Bovee-
Oudenhoven et al., 1996, 1997; Bovee Oudenhoven et al., 1997,
1999) and clinical trials on humans (Bovee-Oudenhoven et al.,
2003; Cheng et al., 2013; Dadu et al., 2015) using calcium or other
CaSR ligands indicate that activation of this nutrient sensing
receptor in vivo does reduce symptoms of infectious diarrheas
(also see recent review by Cheng, 2016).
With regards to the mechanisms for the effects of CaSR
on ion transport, it has been postulated that CaSR agonists
enhance cyclic nucleotide destruction via G protein-mediated
activation of PDE, instead of inactivation of adenylyl cyclase
found in non-intestinal cells (Geibel et al., 2006). Consistent with
this notion, inhibition of net fluid secretion by CaSR agonists
correlated with reductions in cyclic nucleotide accumulations,
both of which were abolished by IBMX (Geibel et al., 2006).
IBMX is a non-specific PDE inhibitor. It remains unclear which
specific isoform of PDE in the intestinemediates the CaSR action.
Also unknown is the mechanism by which CaSR activates PDE.
There are 11 families of cyclic nucleotide-degrading PDEs, each
exhibiting selective affinities for degrading cAMP and/or cGMP
(Beavo, 1995; Jeon et al., 2005). Although little information
is available on the specific PDE genes expressed in intestinal
epithelial cells, PDE1-5 isoforms have been identified in human
colon cancer cells (Soh et al., 2000; O’Grady et al., 2002), and
each of these PDEs is sensitive to IBMX. Because inhibition
of PLC signaling abolishes CaSR effects on cAMP and cGMP
accumulation (Geibel et al., 2006), it is tempting to speculate
that activation of Ca2+i /calmodulin-dependent PDE1 may be
responsible. Future work is needed to determine whether PDE1
is activated by CaSR, and if so, how it is activated. Also needed
to be elucidated are the mechanisms for how CaSR regulates and
coordinates distinct ion channels and transporters in secretion
and absorption, and whether CaSR regulates absorption by
surface/villous cells using the same or different mechanism than
CaSR regulates secretion by crypts. CaSR binds a plethora of
ligands, interacts with multiple G protein subtypes, and regulates
divergent downstream signaling pathways. It is possible that
CaSR may use a completely different mechanism to regulate
the same type of function in a different cellular context. For
example, a recent study by Xie et al. (2014) showed that in the
duodenum CaSR seems to employ an alternative intracellular
signaling pathway to increase HCO−3 secretion in this tissue.
This alternative pathway involves Ca2+i -dependent activation
of receptor-operated channel, intermediate conductance K+
channels, and CFTR. Similarly, Brennan et al. (2016) recently
reported CaSR stimulation of CFTR in developing human fetal
lung. This stimulatory effect of CaSR appears to be mediated
through a Ca2+i -dependent adenylyl cyclase.
CaSR AND ENS ACTIVITY AND MOTILITY
As previously mentioned, the ENS is the brain of the gut.
The ENS comprises two plexuses—the submucosal Meissner’s
plexus and the myenteric Auerbach’s plexus. While the former
controls secretion, the latter regulates motility (see Figure 1D).
CaSR is expressed in both plexuses (nerve fibers and somas;
Chattopadhyay et al., 1998; Cheng et al., 1999; Cheng, 2012),
suggesting its potential role in controlling the activity and
functions of these enteric neurons.
CaSR Inhibits ENS Activity and
ENS-Mediated Secretion
In mammals (humans and rodents), as much as 80–90% of
the fluid secreted at basal condition, during digestion, and in
diarrheas (cholera and rotavirus) are ENS-mediated (Burleigh
and Borman, 1997; Lundgren et al., 2000; Lundgren, 2002; Field,
2003; Farthing, 2006; Lorrot and Vasseur, 2007). These estimates
are based on the magnitude to which the fluid secreted or
current evoked is inhibited by tetrodotoxin (TTX) or lidocaine.
As selective inhibitors of voltage-gated Na+ channels in neural
tissues, TTX and lidocaine are used to inhibit neurotransmission,
and subsequently ENS activity. Using this method, TTX-sensitive
Isc responses in freshly isolated, intact ENS-containing rat colon
segments mounted onto Ussing chambers were measured, and
effects in the presence versus absence of serosally added R568
were compared (Cheng, 2012; Cheng et al., 2012). In these
experiments, TTX-sensitive Isc was employed as a measure of
ENS activity and ENS-mediated anion secretion, and serosal
R568 was applied to activate CaSR in the ENS. Consistent with
active regulation of secretion by the ENS, a large portion (∼70–
75%) of Isc in the proximal and distal colon was inhibited by
TTX, both at basal and under cAMP (forskolin or cholera toxin)-
stimulated conditions. Furthermore, the addition of forskolin or
cholera toxin increased TTX-sensitive Isc; subsequent addition
of R568 to the serosal bath to activate CaSR in the ENS
abolished the secretagogue-stimulated TTX-sensitive Isc. Similar
effects of R568 addition were also observed on basal TTX-
sensitive Isc. These results demonstrate that CaSR agonists
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function as inhibitors of ENS activity, reducing ENS-mediated
secretion. These findings also point to a dual model for regulating
intestinal fluid transport, in which neuronal and non-neuronal
secretagogue actions are modulated by the inhibitory effects of
CaSR on the ENS—which is TTX/lidocaine-sensitive—as well as
by CaSR on the epithelium—which is TTX/lidocaine-insensitive.
Clearly, further studies are needed to address these possibilities.
Also, future experiments will be required to understand which
type of neuron(s) in the ENS expresses and is affected by
CaSR and to determine what the intracellular second messenger
mechanism(s) is involved in this process.
CaSR Inhibits Motility
CaSR is also present in the myenteric Auerbach’s plexus that
governs gut motility (Chattopadhyay et al., 1998; Cheng, 2012).
Thus, CaSR may play a role in regulating motility as well.
In support of this notion, people who take high calcium are
often constipated (Prince et al., 2006), as are patients with
hypercalcemia (Ragno et al., 2012). Likewise, animals receiving
treatment of polyamines (e.g., spermine) or peptides (e.g., γ-
glutamyl cysteine), both of which are classes of agonists for CaSR,
display profound inhibition on gastric emptying and/or intestinal
motor activity (Belair et al., 1981; Tansy et al., 1982; Muramatsu
et al., 2014). Polyamine inhibition of GI transit is also noted in
several rodent models of diarrhea-dominate forms of irritable
bowel syndrome (Bergeron et al., 1996, 2001a,b). Together, these
studies highlight the importance of this nutrient sensing receptor
in modulating ENS activity and gut motility.
The physiological and pathophysiological significance of
these findings remains to be determined. Since the enteric
nerve network follows the nutrient-carrying blood and lymph
vessel networks, CaSR may provide a mechanism for the
ENS to sense nutrients and fine-tune its activity and function
in accordance with the status of digestion and absorption.
For example, upon food ingestion, mechanical signals activate
the ENS, enhancing its functions in promoting secretion and
motility to facilitate digestion; upon completion of digestion,
the chemical signals (e.g., absorbed nutrients) carried in the
parallel blood or lymph vessels may activate CaSR to deactivate
the ENS, thereby slowing down secretion and motility in order
to facilitate absorption. Considering its normal role in the
gut, CaSR may represent an excellent candidate gene to be
investigated in the pathophysiology of irritable bowel syndrome
(IBS), a common clinical condition characterized by chronic
diarrhea and/or constipation, in addition to abdominal pain
and cramping. Given the key CaSR function in regulation and
coordination of secretion and muscular contraction, it is possible
that over activity of the CaSR may result in under-activation
of the ENS, leading to the constipation-dominate form of IBS
(IBS-C). Likewise, reduced activity of the CaSR may result
in excessive activation of the ENS, leading to the diarrhea-
dominate form of IBS (IBS-D). Clearly, more work is needed
to verify these hypotheses in IBS patients, like the one that
has recently been published (Romero et al., 2015) even if this
latter study revealed no association between the common CaSR
polymorphism rs1801725 and IBS.
CaSR AND INTESTINAL BARRIER
INTEGRITY AND IMMUNITY
In addition to modulating the absorption of nutrients and
secretion of electrolytes and fluids, the intestinal epithelial
barrier, with its intercellular tight junctions, also controls the
passage of gut microbes across the mucosa. This is to avoid
over-activating the sub-epithelial immune cells, mainly dendritic
cells (DCs), T cells, and B cells, thereby preventing local
and systemic inflammation (Turner, 2006). More recently, our
laboratory illustrated the role of CaSR and the consequence of
its manipulation both locally and systemically using intestinal
epithelium-specific CaSR−/− mice (villinCre/Casrflox/flox; Cheng
et al., 2014). We found that epithelial CaSR is also an
important regulator of intestinal barrier integrity and immunity,
as well as a key modulator of gut bacteria-sensing. Epithelial
CaSR deficiency resulted in diminished intestinal barrier
function, altered composition and distribution of the gut
bacteria, and skewed immunity toward a pro-inflammatory
response (Cheng et al., 2014). These observations strongly
support the notion that the epithelial barrier plays an
important role in triggering immune activation and gut
inflammation.
CaSR Contributes to Intestinal Barrier
Integrity
In contrast to transcellular transport, in which ions and solutes
travel through the epithelial cell passing through both the apical
and basolateral membranes, paracellular transport refers to the
transfer of ions and substances across the intestinal epithelium
by passing through the intercellular space between the cells.
Situated between adjacent intestinal epithelial cells of the mucosa
are structures called apical junctional complexes, such as tight
junctions (TJs; Figure 1C). These intercellular structures, along
with the layer of epithelium composing the intestinal mucosa, act
as a barrier separating the luminal contents from the submucosal
compartment, which is home to the gut immune system. TJs
harbor complex interactions between∼40 proteins, including the
transmembrane proteins occludins and claudins. These proteins
are anchored to the actin filaments and myosin light-chain
through the zonula occludens family. Breaching of this dynamic
barrier may result in excessive exposure of the gut immune
system to luminal microbes and foreign antigens, leading to
intestinal inflammation (Turner, 2006). Since it is well-known
that Ca2+o is required for the development (Martinez-Palomo
et al., 1980; Cereijido et al., 1981; Gonzalez-Mariscal et al., 1985)
and the maintenance (Galli et al., 1976; Meldolesi et al., 1978;
Palant et al., 1983) of stable epithelial TJs between epithelial
cells, we hypothesized that CaSR may participate in regulating
TJ assembly/formation and paracellular permeability.
Figure 2 shows the hypothesized mechanism for how CaSR
produces its effects on the control of intestinal epithelial barrier
permeability and inflammation. According to a current model of
IBD (Turner, 2006), intestinal inflammation is induced by a self-
amplifying pathway where a limited amount of luminal bacteria
or bacteria-derived molecules cross the epithelium to activate
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FIGURE 2 | Schematic representation of the colonocytes showing how deficiency in intestinal CaSR results in increased gut permeability and
inflammation. Central panel, illustrates a current model of self-amplifying pathway for intestinal disease (Turner, 2006) where a small amount of luminal bacteria or
bacteria-derived molecules pass across the epithelium to activate lamina propria immune cells, leading to secretion of proinflammatory cytokines (e.g., TNFα) and
subsequent activation of their receptors (e.g., TNFR) in the epithelium. The latter increases MLCK transcription and activity and phosphorylation of myosin light chain
(MLC), resulting in increased contractility of perijunctional actin-myosin ring and increased epithelial permeability. The consequences are greater access leakage of
luminal materials, greater immune activation, and even greater barrier defects. The presence of CaSR ligands and signals limits amplifying of this cascade through
activation of phosphodiesterase (PDE) (Geibel et al., 2006) and inhibition of MLCK (Cheng et al., 2014), leading to MLC dephosphorylation and barrier stabilization.
Thus, in the presence of intact CaSR signaling, as in CaSR+/+ mice, immune tolerance or only low-grade inflammation is seen (Right panel). However, in the
absence of CaSR signal, as in CaSR−/− mice, the limiting of this cascade amplification is lost, leading to immune activation and uncontrolled inflammation (Macleod,
2013b; Cheng et al., 2014) (Left panel).
lamina propria immune cells. This leads to secretion of pro-
inflammatory cytokines (e.g., TNFa) and subsequent activation
of their receptors (e.g., TNFR) in the epithelium. The latter
increasesmyosin light-chain kinase (MLCK) transcription via the
IKKβ, IκBα, and NF-κB signalosome, and then phosphorylates
the regulatory myosin light chain (MLC). The result of this is
increased contraction of a band of actin and myosin (actin-
myosin ring) located at the tight junctions, which subsequently
promotes epithelial permeability. The consequences include
greater access leakage of luminal materials, greater immune
activation, and even greater barrier defects. CaSR limits the
amplification of this cascade through receptor-mediated Gαq/11-
dependent activation of PDE (Geibel et al., 2006) and inhibition
of NF-κB phosphorylation. As a result, MLCK is down-regulated,
MLC phosphorylation inhibited, and epithelial barrier stabilized.
Hence, in the presence of intact CaSR signaling, immune
inactivation or tolerance is maintained. Conversely, in the
absence of CaSR, ligands, or signals, as in CaSR−/− mice, this
cascade is self-amplified, leading to immune activation and
uncontrolled inflammation.
To test this hypothesis, we examined the intestinal
permeability of CaSR null mice (villinCre/Casrflox/flox)
lacking CaSR in the intestinal epithelium ex vivo using the
aforementioned Ussing chamber technique (Cheng et al., 2014).
Compared to wild type controls, CaSR−/− mice displayed
significantly lower transepithelial electrical resistance, higher
conductance, and higher passive transport of FITC-conjugated
dextran (Cheng et al., 2014). Surprisingly, significant alterations
in Isc and ion transporter transcript expressions, indicative of
defective transcellular transport, were not observed in CaSR−/−
mice (Cheng et al., 2014). This suggests that, unless in minute-
to-minute regulations—as detailed in previous sections—in
Frontiers in Physiology | www.frontiersin.org 10 June 2016 | Volume 7 | Article 245
Tang et al. CaSR in Intestinal Physiology and Immunology
the setting of long-term regulation, CaSR appears to affect the
paracellular transport pathway exclusively.
Consistent with a defective intestinal barrier, CaSR−/− mice
showed decreased colonic epithelial expression of TJ molecules,
particularly claudin-2, a major component of TJs, whereas
expression of MLCK-1 was found to be significantly increased
(Cheng et al., 2014). Also increased was the expression of the TJ
protein Cingulin in CaSR−/− mice compared to their wild type
counterparts (Cheng et al., 2014). Although the exact function
is unknown, Cingulin has been associated with the expression of
occludin and claudins, and the epithelial specific transcription
factorsGata4,Gata6 andHif-1α, which is a feature also embodied
by CaSR−/− mice (Cheng et al., 2014).
CaSR Regulates Gut Bacteria Sensing and
Balance
Besides handling dietary nutrients, the mammalian gut harbors a
huge number (1013–1014) of microorganisms, collectively known
as microbiota, especially in the colon. With the utilization of
improved techniques measuring gut microbiota composition
and function, such as 16S rDNA high-throughput sequencing,
a growing number of research studies have shed light on
the mutual relationship and bidirectional interactions between
gut microbiota and nutrition (see recent reviews Flint et al.,
2012; Maukonen and Saarela, 2015). For example, while energy
extraction and metabolism are greatly influenced by these gut
microbes, the composition and activity of these microbes are
also substantially affected by the energy (diet and nutrients)
one consumes. Multiple mechanisms are proposed to explain
these interactions. We hypothesized that CaSR as a sensor
for many nutrients may be involved in gut bacteria-sensing
and ecosystem-balancing, regulating the nutrition-microbial-
host interactions. To examine this, we analyzed and compared
the microbiota of steady-state CaSR−/− and wild type mice
using the 16S rDNA sequencing technique. We found that
deficiency in epithelial CaSR altered the gut’s microbe balance
(Cheng et al., 2014). At the phylum level, an outgrowth in
Deferribacteraceae was noted, which has previously been found
to correlate with inflammatory responses in the colons of
Citrobacter rodentium-infected mice (Hoffmann et al., 2009), a
model of bacterial colitis. Concurrently, beneficial Lactobacilli
and Clostridium were decreased in CaSR−/− mice (Cheng et al.,
2014). Furthermore, the relative abundance and distribution
of the gram-positive organism Clostridium coccoides was also
significantly altered in CaSR−/− mice, with depletion noted in
the lumen and enrichment in the sub-epithelial layer. Consistent
with enhanced bacterial translocation and dissemination in host
tissues, CaSR−/− mice had significantly decreased epithelial
expression of Reg3β and Reg3γ, which encode secreted C-
type lectins that bind and protect against translocation and
dissemination of Gram-negative (van Ampting et al., 2012) and
Gram-positive bacteria (Cash et al., 2006; Brandl et al., 2007),
respectively.
In addition to detecting “health signals” (i.e., nutrients),
CaSR has recently been shown to be involved in the detection
of “danger signals” derived endogenously [e.g., Ca2+ released
as a result of tissue injury (Lee et al., 2012)] or exogenously
[e.g., chitin and chitosan (Huang et al., 2015; Muanprasat
et al., 2015)]. Since these endogenous and exogenous danger
signals are two types of molecules that belong to so-called
damage-associated molecule patterns (DAMPs) and pathogen-
associated molecule patterns (PAMPs), and are also ligands
of the primitive pattern recognition receptors (PRRs), it is
reasonable to speculate that CaSR and PRR—two ancient
basic sensing mechanisms—may communicate in a way to
detect an appropriate level of danger in the gut. Indeed,
intestinal epithelial cells were found to express all PRRs that
recognize different ligands. These include Toll-like receptors
(TLRs), C-type lectins, nucleotide-binding domain and leucine-
rich repeat-containing receptors (NLRs), and retinoic acid-
inducible gene I-like receptors (RLRs) (Abraham andMedzhitov,
2011; Cheng et al., 2014). When CaSR function was lost, all
the PRRs were up-regulated (Cheng et al., 2014). Thus, it
is likely that CaSR may normally antagonize PRR signaling
and keep the latter in check. Alternatively, PRRs may be up-
regulated in CaSR−/− mice to compensate for the lost CaSR
function. Similar studies that examine CaSR expression and
function in PRR-deficient mice would help to address these
possibilities.
Of the greatest relevance is probably the ability of the
microbiota to produce polyamines, spermine (tetra-amine),
spermidine (tri-amine), and their di-amine precursor putrescine.
As alkaline molecules, these polycationic polyamines are fully
protonated in physiologic solutions so that they resemble
multivalent metal cations Ca2+ and Mg2+ and can thereby
participate in many biological processes required for the
maintenance of gut epithelium health (Dufour et al., 1988;
Buts et al., 1993; Loser et al., 1999). In the gut, while
virtually every microbiome has genes for polyamine synthesis,
the major polyamine-producers are Bacteroides, Enterobacteria,
and Fusobacterium (Noack et al., 1998; Sabater-Molina et al.,
2011). Among the three, Bacteroides is the most predominant
species of the gut flora, particularly in those individuals
who consume protein and animal fat. Pectin, fructans, and
other indigestible carbohydrates and dietary fiber (collectively
called prebiotics) are known to be beneficial to the host. It
has been postulated that this benefit is attributed to their
fermentation end products short-chain fatty acids. New emerging
evidence, however, suggests that prebiotics are also beneficial
because they select polyamine-producing microflora (Noack
et al., 1998; Delzenne et al., 2000; Sabater-Molina et al.,
2011). In the colon, polyamines, specifically spermine, are
potent positive allosteric modulators of CaSR (Cheng et al.,
2004). In the presence of physiological or near physiological
concentrations of Ca2+o , as low as a few nM of spermine added
luminally or basolaterally was found to produce significant
biological effects such as inhibition of cAMP-dependent fluid
secretion by colonic crypts (Cheng et al., 2004). Thus, the
bacterial polyamine-activated CaSR signaling may very well
be involved in the cross-talk between the microbiome and
the epithelium—an absolutely essential process required for
the proper development of both innate and adaptive immune
responses.
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CaSR Regulates Intestinal Innate and
Adaptive Immune Responses
The colon is in a constant state of inflammation, the magnitude
of which is controlled largely by the integrity of the intestinal
barrier and themicrobiota. Speculating that dysbiosis may lead to
pathogenic inflammatory immune responses locally, gene array
analyses of the distal colon of wild type and CaSR−/− mice
were performed (Cheng et al., 2014). As expected, the colon
of CaSR−/− mice showed a marked increase in expression of
an array of cytokine-encoding genes, including IL-1β, TNF-
α, INF-γ, IL-6, IL-12, IL-17, IL-22, IL-23, NO synthase 2,
and prostaglandin E synthase 3. These changes in cytokine
expression are likely attributed to the CaSR null epithelium
because similar changes in expression were noted in vitro in
cultured colonic epithelial cells as well (Mine and Zhang, 2015;
Zhang et al., 2015). Increased IL-1R expression was also seen in
colonic DCs in CaSR−/− mice, as well as in colonic CD4+ and
CD8+ T lymphocytes. As further evidence of chronic intestinal
inflammation in CaSR−/− mice, higher IL-1R and programmed
cell death protein 1 (PD-1) were significantly expressed in colonic
CD4+ and CD8+ T cells, and increased number of B cells
with higher levels of IgA expression was found to accumulate
in the colon. Moreover, compared to their wild type littermate
counterparts, CaSR−/− mice demonstrated more severe colitis
in response to challenge by dextran sodium sulfate (DSS). Their
recovery was also significantly delayed, both clinically, as assessed
by changes in body weight, stool consistency and stool blood,
and histologically, as demonstrated by alterations in colonic
inflammation and mucosal damage.
Thus, our CaSR−/− mice studies demonstrated that a
healthy epithelial CaSR signal is required for the maintenance
of a functional epithelial barrier, a symbiotic microbial-host
interaction, and a balanced immune system; deficiency in
CaSR results in compromised barrier function and increased
translocation of bacteria that trigger the immune system, thereby
potentiating this cycle, ultimately leading to inflammation.
Still, many questions remain to be addressed. For example,
CaSR is lost in colon cancer (Sheinin et al., 2000; Fetahu
et al., 2014, 2016). What happens to CaSR in the colons of
IBD patients and animal models of DSS or infectious diarrhea?
Is the expression or function of the CaSR altered as a result
of inflammation or due to responsiveness to nutrients or
allosteric modulators, as recently demonstrated in transformed
colonic cells (Fetahu et al., 2014)? In IBD, there are significant
changes to the ENS and neuroplasticity (Lomax et al., 2005);
is CaSR involved? If so, what are the consequences to motility,
neurosecretion, epithelial, and immune function?
SUMMARY AND CONCLUSIONS
In summary, we have shown that gut epithelium CaSR, a
fundamental mechanism for sensing and regulating ionic and
nutrient compositions of extracellular milieu in the small and
large intestine, controls digestion, absorption, and secretion.
Consequently, during the digestion phase (i.e., when food is
ingested into the stomach before nutrients are released), CaSR
stimulates secretion to aid in food breakdown; in contrast,
during the absorptive phase (i.e., when nutritional signals are
fully extracted and have reached the absorptive gut of the small
intestine), CaSR stimulates absorption and inhibits secretion
so as to terminate digestion and complete the cycle. We
have also provided evidence that this same receptor controls
intestinal permeability and immunity. Thus, whereby disrupting
or inhibiting this nutrient-sensing mechanism may be associated
with over-activation of the immune system and loss of immune
tolerance, activating CaSR expression and activity would be
helpful, not only in the maintenance of a balanced immune
system, but also in deactivating the over-activated immune
responses and restoring immune homeostasis. These results
suggest a new paradigm for regulation of intestinal physiology
and immunology, in which both fluid metabolism and immune
balance may be fine-tuned by CaSR in accordance with nutrient
availability and the state of digestion and absorption. Most of the
studies so far are conducted in vitro or based on observations
made from ex vivo tissues. Future studies need to define CaSR
effects in vivo in animal models and transgenic mice before CaSR
agonist clinical trials are performed in diarrheal patients.
Acute infectious diarrhea remains the number one cause of
death among young children, particularly in developing nations.
It is estimated that 1.3 million children die each year, not due
to infection per se, but as a result of the associated diarrhea and
dehydration. Although oral rehydration solution is valuable for
correcting dehydration, so far there is no cost-effective therapy
to stop this ongoing loss of fluid and to reduce the duration of
diarrhea. Likewise, on the other end of the spectrum, chronic
inflammatory, and neurogenic diarrhea, such as those caused by
IBD and IBS, is a major health problem in developed countries.
It is especially prevalent among adolescents and young adults,
affecting ∼5% of the population. Although an increased number
of treatment options have become available, there is currently no
cure for these conditions. Total enteral nutrition is an effective
primary therapy for Crohn’s disease, but the exact mechanism
of action remains unspecified. The ability of CaSR agonists to
reverse increased intestinal secretion and decreased absorption
induced by bacterial enterotoxins, diminish overly active enteric
nerve activity and motility, as well as restore compromised
barrier function and imbalanced immune responses suggests
that modulations of CaSR expression and activity using calcium
mimetic or a combination of specific nutrients may provide a
novel therapeutic approach for secretory diarrhea, IBS, and IBD.
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